Have a personal or library account? Click to login
Carotid artery stiffness, digital endothelial function, and coronary calcium in patients with essential thrombocytosis, free of overt atherosclerotic disease Cover

Carotid artery stiffness, digital endothelial function, and coronary calcium in patients with essential thrombocytosis, free of overt atherosclerotic disease

Open Access
|Jan 2017

Figures & Tables

Recruitment of essential thrombocytosis (ET) and control subjects for the cross-sectional study of endothelial function and preclinical atherosclerosis.
Recruitment of essential thrombocytosis (ET) and control subjects for the cross-sectional study of endothelial function and preclinical atherosclerosis.
Correlation of the Framingham coronary heart disease (CHD) risk and coronary calcification (Agatston score). While a significant Pearson correlation between the Framingham CHD risk and the Agatston score was found for control subjects (r = 0.577, p < 0.001), no significant correlation was found for the patients with essential thrombocytosis (ET).
Correlation of the Framingham coronary heart disease (CHD) risk and coronary calcification (Agatston score). While a significant Pearson correlation between the Framingham CHD risk and the Agatston score was found for control subjects (r = 0.577, p < 0.001), no significant correlation was found for the patients with essential thrombocytosis (ET).

Coronary calcium burden_ Median and interquartile range are given for the Agatston score of coronary calcification, and the number of subjects with an Agatston score of > 160 is given_ The comparison between groups were tested by χ-square1- or Mann-Whitney test2

Coronary calcuim burdenET patients (n= 40)Control group (n= 42)Comparison between groups (p)
2Agatston score0.1 (0-16.85)0 (0-8.55)0.26
1Agatston score > 160 (yes/no)6/340/42<0.01

Endothelial function of the digital arteries - reactive hyperemia index (RHI) and estimate of vascular stiffness - augmentation index (AI)_ Means and standard deviations are given for the normally distributed RHI, medians and interquartile range are given for non-normally distributed AI_ Comparisons between groups were tested by the Student’s t-test1, or the Mann-Whitney test2

ET patients (n= 40)Control group (n= 42)Comparison between groups (p)
1RHI2.10 (0.57)2.35 (0.62)0.07
2AI [%]19 (3-30)13 (5-22)0.38

Blood cell count and C-reactive protein (CRP)_ Mixed cells denote a composite reading for monocytes, eosinophils and basophils_ When CRP was reported as < 5 mg/L, a value of 2_5 mg/L was ascribed to the subject, therefore the CRP values are only an approximation_ Mean and standard deviation are shown for normally distributed data; median and interquartile range are given for non-normally distributed data_ The comparisons between groups were tested by Student’s t-test1, or by Mann-Whitney test2

VariableET patients (n= 40)Control group (n= 42)Comparison between groups (p)
1Red blood cells [10^12/L]4.37 (0.67)4.76 (0.41)<0.01
1 Platelets [10^9/L]509 (182)243 (53)<0.001
1Leukocytes [10^9/L]7.60 (3.00)7.02 (1.63)0.28
1Lymphocytes [10^9/L]1.67 (0.80)2.23 (0.75)<0.01
1 Neutrophils [10^9/L]5.15 (2.48)4.15 (1.20)0.02
2Mixed cells [10^9/L]0.6 (0.4-0.9)0.6 (0.5-0.7)0.76
2CRP [mg/L]5.0 (2.5-8.4)5.4 (2.5-6.1)0.27

Asymptomatic carotid plaques, carotid β-stiffness index and estimated pulse wave velocity_ Mean and standard deviation are given for normally distributed continuous data, median and interquartile range are given for non-normally distributed continuous data and the number of subjects with a carotid plaque score of ≥2 is given_ Comparisons between groups were tested by: χ-square1, Student’s t-test2, or the Mann-Whitney test3

ET patients (n= 40)Control group (n= 42)Comparison between groups (p)
3 Carotid plaque score1 (0-1.25)0 (0-2)0.30
1 Carotid plaque score ≥2 (yes/no)10/3014/280.41
2β-stiffness index7.75 (2.34)8.44 (2.81)0.23
2pulse wave velocity (m/s)6.21 (1.00)6.45 (1.04)0.46

Cardiovascular 10-year risk estimation by the Framingham risk equations_ Median and interquartile range are shown_ Comparisons between groups were tested by the Mann-Whitney test

Framingham 10-year risk calculation (%)ET patients(n= 40)Control group (n= 42)Comparison between groups (p)
CHD7.80 (3.98-13.73)7.20 (3.57-11.37)0.52
MI2.87 (1.25-6.72)2.17 (0.77-4.73)0.47
Stroke2.93 (1.19-5.37)2.59 (1.49-4.09)0.73
CVD14.56 (7.16 – 23.68)12.99 (6.43-19.52)0.84

Baseline characteristics_ Numbers of subjects are given for discrete data_ Mean and standard deviation are shown for normally distributed continuous data; median and interquartile range are given for non-normally distributed continuous data_ Comparisons between groups were tested by χ-square1, Student’s t-test2, or Mann-Whitney test3

VariableET patients (n= 40)Control group (n= 42)Comparison between groups (p)
2 Age (years)57.1 (14.1)58.2 (13.1)0.71
1 Sex (M/F)14/2616/260.77
2 BMI (kg/m2)25.4 (3.5)27.0 (4.5)0.07
2 Waist circumference (cm)
M95.4 (10.4)101.1(10.2)0.14
F89.7 (8.8)89.4 (13.6)0.92
3 Systolic blood pressure (mmHg)139 (129-148)136 (130-143)0.33
3 Diastolic blood pressure (mmHg)80 (73-89)80 (74-87)0.92
2Total cholesterol (mmol/l)5.01 (1.07)5.23 (0.83)0.30
2LDL-cholesterol (mmol/l)2.73 (0.77)2.86 (0.69)0.42
2HDL-cholesterol (mmol/l)1.44 (0.48)1.63 (0.48)0.07
2Triglycerides (mmol/l)1.82 (0.79)1.65 (0.82)0.33
1 Current smoking (yes/no)5/353/390.41
1 Ever smoking (yes/no)16/2411/310.12
1Diabetes (yes/no)3/370/420.07
3Serum glucose (mmol/l)5.4 (4.7-6.1)5.1 (4.8-5.6)0.64
Kidney disease (yes/no)0/400/42-
2Serum creatinine (μmol/l)75.7 (15.0)75.7 (14.1)0.99
Family history of premature CVD (yes/no)0/400/42-
1Family history of CVD (yes/no)16/2416/260.86
DOI: https://doi.org/10.1515/raon-2017-0006 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 203 - 210
Submitted on: Sep 21, 2016
|
Accepted on: Dec 17, 2016
|
Published on: Jan 14, 2017
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2017 Matjaz Vrtovec, Ajda Anzic, Irena Preloznik Zupan, Katja Zaletel, Ales Blinc, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.